Restrictive atrial dysfunction in cardiac amyloidosis: differences between immunoglobulin light chain and transthyretin cardiac amyloidosis patients

HIGHLIGHTS

• who: Mathijs O. Versteylen and colleagues from the Department of Cardiology, University Medical Center Utrecht, POBox, GA Utrecht, The Netherlands have published the research work: Restrictive Atrial Dysfunction in Cardiac Amyloidosis: Differences between Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patients, in the Journal: Biomedicines 2022, 10, 1768. of /2022/
• what: All of the included patients provided written informed consent, and the study was approved by the Medical Ethics Committee of the University Medical Center Utrecht (non-WMO 19/222) and conducted in accordance with the Declaration of Helsinki. The difference in left atrial function . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.